NCT05913817 The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. Status COMPLETED Phase N/A
NCT05896527 A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT05891964 Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital. Status COMPLETED Phase PHASE4
NCT05855967 A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India Status COMPLETED Phase PHASE4
NCT05835843 Study to Assess the Reliability of PASI Scoring Using Digital-Based Images Status COMPLETED Phase N/A
NCT05811234 A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults Status COMPLETED Phase N/A
NCT05772520 The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT05763082 Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT05739435 Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05725057 Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT05650060 Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis Status COMPLETED Phase N/A
NCT05600036 A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT05565560 A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05531682 A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT05510063 Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT05509361 Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis Status COMPLETED Phase PHASE3
NCT05442788 A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE1